Market Research Logo

ALK-Abello AS (ALKB) - Financial and Strategic SWOT Analysis Review


Attention: There is an updated edition available for this report.

ALK-Abello AS (ALKB) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

ALK-Abello A/S (ALK) is a research-driven pharmaceutical company which discovers, develops and commercializes immune-therapeutics for allergy prevention, diagnosis and treatment. The company specializes in allergy research and allergy immunotherapy. Its product portfolio includes allergy immunotherapy products such as tablet-based allergy vaccines, sublingual or drop-based allergy vaccines, and subcutaneous allergy vaccines; adrenaline auto-injector for emergency treatment; and other allergy diagnostics. ALK’s research and development pipeline products including sublingual allergy immunoterapy tablets for addressing the ragweed, house dust mite and tree pollen allergy. The company’s products are targeted at the treatment of allergies due to grass pollen, tree pollen, ragweed pollen, house dust mites and cat allergy. It has subsidiaries in Austria, Canada, Denmark, France, Germany, Italy, the Netherlands, Poland, Norway, Spain, Switzerland, Sweden, the UK and the US. ALK is headquartered in Horsholm, Denmark.

ALK-Abello AS Key Recent Developments

May 17, 2016: ALK appoints Carsten Hellmann as new President and CEO
May 04, 2016: ALK-Abello: Three-month interim report 2016
Feb 22, 2016: ALK's CEO Jens Bager steps down
Feb 09, 2016: ALK releases its annual report 2015
Aug 18, 2015: Six-month interim report (Q2) 2015 for ALK

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
ALK-Abello A/S - Key Facts
ALK-Abello A/S - Key Employees
ALK-Abello A/S - Key Employee Biographies
ALK-Abello A/S - Major Products and Services
ALK-Abello A/S - Pharmaceutical Pipeline Products Data
ALK-Abello A/S, Pipeline Products by Therapy Area
ALK-Abello A/S, Pipeline Products by Development Phase
ALK-Abello A/S - History
ALK-Abello A/S - Company Statement
ALK-Abello A/S - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
ALK-Abello A/S - Business Description
ALK-Abello A/S - Corporate Strategy
ALK-Abello A/S - SWOT Analysis
SWOT Analysis - Overview
ALK-Abello A/S - Strengths
Strength - Research and Development Activities
Strength - Core Products: SCIT and SLIT-Drops
Strength - Dominant Position
ALK-Abello A/S - Weaknesses
Weakness - Dependence on Third Parties
Weakness - Increasing Trade Receivables
ALK-Abello A/S - Opportunities
Opportunity - Strategic Agreements
Opportunity - Product Pipeline
Opportunity - Product Approvals and Launches
ALK-Abello A/S - Threats
Threat - Foreign Exchange Risk
Threat - Uncertain R&D Outcomes
Threat - Regulatory Environment
ALK-Abello A/S - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ALK-Abello A/S, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
ALK-Abello A/S, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
ALK-Abello A/S, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 17, 2016: ALK appoints Carsten Hellmann as new President and CEO
May 04, 2016: ALK-Abello: Three-month interim report 2016
Feb 22, 2016: ALK's CEO Jens Bager steps down
Feb 09, 2016: ALK releases its annual report 2015
Aug 18, 2015: Six-month interim report (Q2) 2015 for ALK
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
ALK-Abello A/S, Key Facts
ALK-Abello A/S, Key Employees
ALK-Abello A/S, Key Employee Biographies
ALK-Abello A/S, Major Products and Services
ALK-Abello A/S, Number of Pipeline Products by Therapy Area
ALK-Abello A/S, Number of Pipeline Products by Development Stage
ALK-Abello A/S, Pipeline Products By Therapy Area and Development Phase
ALK-Abello A/S, History
ALK-Abello A/S, Other Locations
ALK-Abello A/S, Subsidiaries
ALK-Abello A/S, Key Competitors
ALK-Abello A/S, Ratios based on current share price
ALK-Abello A/S, Annual Ratios
ALK-Abello A/S, Interim Ratios
ALK-Abello A/S, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
ALK-Abello A/S, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
ALK-Abello A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
ALK-Abello A/S, Pipeline Products by Therapy Area
ALK-Abello A/S, Pipeline Products by Development Phase
ALK-Abello A/S, Performance Chart (2011 - 2015)
ALK-Abello A/S, Ratio Charts
ALK-Abello A/S, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
ALK-Abello A/S, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report